Equity Capital Markets

Company · CIK 1722964

Y-mAbs Therapeutics, Inc.

CIK1722964 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressNJ
Listedno ticker on SEC record today
First annual or quarterly report2018-11-13

Offerings

3 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-271006
ShelfEffective
 2023-03-302025-09-164
333-234034
ShelfEffective
 2019-10-012021-02-186
333-226999
IPOFinal prospectus
 2018-08-242018-09-244

Filings

15
FiledFilingRegistrationAccession
2025-09-16EFFECTDeclared effective 333-2710069999999995-25-002969
2025-03-04424B5Shelf takedown 333-2710060001558370-25-002173
2023-05-05EFFECTDeclared effective 333-2710069999999995-23-001320
2023-03-30S-3Shelf registered 333-2710060001558370-23-005145
2021-02-18424B5Shelf takedown 333-2340340001047469-21-000388
2021-02-17424B5Shelf takedown 333-2340340001047469-21-000369
2019-10-31424B5Shelf takedown 333-2340340001047469-19-005986
2019-10-29424B5Shelf takedown 333-2340340001047469-19-005954
2019-10-15EFFECTDeclared effective 333-2340349999999995-19-002314
2019-10-01S-3Shelf registered 333-2340340001558370-19-008756
2018-09-24424B4Final prospectus 333-2269990001047469-18-006346
2018-09-20EFFECTDeclared effective 333-2269999999999995-18-002420
2018-09-07S-1/AAmendment 333-2269990001047469-18-006039
2018-08-24S-1Registration filed 333-2269990001047469-18-005786
2018-02-13DRSDraft made public 377-019350000912057-18-000071

All filings of this company · CSV